Pharmaceutical composition for preventing or treating cancer containing receptor tyrosine kinase inhibitor as active ingredient
The present invention relates to a receptor tyrosine kinase activity inhibiting compound represented by Chemical Formula 1 and Chemical Formula 2, wherein the compound represented by Chemical Formula 1 and Chemical Formula 2 has been confirmed to inhibit the growth of cancer cells through inhibiting...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a receptor tyrosine kinase activity inhibiting compound represented by Chemical Formula 1 and Chemical Formula 2, wherein the compound represented by Chemical Formula 1 and Chemical Formula 2 has been confirmed to inhibit the growth of cancer cells through inhibiting kinase activity and has been confirmed to enhance cancer cell apoptosis when used in combination with existing anticancer drugs or radiation therapy. Accordingly, the compound represented by Chemical Formula 1 and Chemical Formula 2 can be provided as a pharmaceutical composition for preventing or treating cancer, or as a composition for increasing the anti-cancer treatment effect of anti-cancer treatments and radiation therapy. |
---|